Entera Bio Ltd — Cash Flow (NASDAQ:ENTX) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 10.42 M9.06 M12.5 M7.31 M6.82 M 7 M Cash from investing activities 86 K17 K102 K17 K3 000 83 K Cash from financing activities 3.92 M25.38 M13 K6.04 M4.48 M 16.75 M Free cash flow 10.42 M9.05 M12.45 M7.29 M6.82 M 6.92 M

Новости

What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)

H.C. Wainwright подтверждает рейтинг "Покупать" для акций Opko Health

Opko Health stock rating reiterated at Buy by H.C. Wainwright

Entera Bio назначает Джено Джермано председателем совета директоров

Entera Bio appoints Geno Germano as board chairman

OPKO and Entera expand collaboration to develop oral PTH treatment

Entera Bio планирует подать заявку в FDA на препарат от остеопороза

Entera Bio plans FDA submission for osteoporosis drug in Q1 2026

H.C. Wainwright подтверждает рейтинг "Покупать" для Entera Bio

H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint

Пероральный аналог ПТГ от Entera Bio показал устойчивый ответ кальция

Entera Bio’s oral PTH analog shows sustained calcium response